88 related articles for article (PubMed ID: 3450183)
1. [DNA cross-links and their biological significance in S180-V mouse tumor cells treated with cisplatin].
He FC; Xia SX
Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):468-70. PubMed ID: 3450183
[No Abstract] [Full Text] [Related]
2. Synergistic effect of oridonin and cisplatin on cytotoxicity and DNA cross-link against mouse sarcoma S180 cells in culture.
Gao ZG; Ye QX; Zhang TM
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):561-4. PubMed ID: 8010060
[TBL] [Abstract][Full Text] [Related]
3. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
[TBL] [Abstract][Full Text] [Related]
4. DNA-protein cross-linking induced by nitracrine in two strains of mouse lymphoma L5178Y cells.
Ciesielska E; Walicka M; Pastwa E; Szmigiero L
Acta Biochim Pol; 1992; 39(1):53-7. PubMed ID: 1441836
[No Abstract] [Full Text] [Related]
5. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
Yang LY; Li L; Keating MJ; Plunkett W
Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of trans-diamminedichloroplatinum(II) and hyperthermia on murine and human tumor cells.
Murthy MS; Travis JD; Erickson LC; Khandekar JD; Scanlon EF
Cancer Res; 1985 Dec; 45(12 Pt 1):6232-7. PubMed ID: 4063974
[TBL] [Abstract][Full Text] [Related]
7. Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum(II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)methylamine.
Zwelling LA; Filipski J; Kohn KW
Cancer Res; 1979 Dec; 39(12):4989-95. PubMed ID: 498125
[No Abstract] [Full Text] [Related]
8. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells.
Laurencot CM; Kennedy KA
Oncol Res; 1995; 7(7-8):371-9. PubMed ID: 8747600
[TBL] [Abstract][Full Text] [Related]
9. In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells.
Samuel SK; Spencer VA; Bajno L; Sun JM; Holth LT; Oesterreich S; Davie JR
Cancer Res; 1998 Jul; 58(14):3004-8. PubMed ID: 9679963
[TBL] [Abstract][Full Text] [Related]
10. Effect of DNA-damaging agents on DNA replication and cell-cycle progression of cultured mouse mammary carcinoma cells.
Kanno S; Hyodo M; Suzuki K; Ohkido M
Jpn J Cancer Res; 1985 Apr; 76(4):289-96. PubMed ID: 3924703
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
Murray D; Jenkins WT; Meyn RE
Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
[TBL] [Abstract][Full Text] [Related]
12. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
[TBL] [Abstract][Full Text] [Related]
13. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
Zwelling LA; Michaels S; Schwartz H; Dobson PP; Kohn KW
Cancer Res; 1981 Feb; 41(2):640-9. PubMed ID: 7192601
[No Abstract] [Full Text] [Related]
14. [Characterization of DNA-protein cross-links forming under the influence of cis-DDP].
Woźniak K; Walter Z
Postepy Hig Med Dosw; 2001; 55(2):275-86. PubMed ID: 11468974
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of intracellular pH regulation induce cisplatin resistance in EMT6 mouse mammary tumor cells.
Laurencot CM; Andrews PA; Kennedy KA
Oncol Res; 1995; 7(7-8):363-9. PubMed ID: 8747599
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
[TBL] [Abstract][Full Text] [Related]
17. [Effects of cisplatin on cultured glioma cells].
Honda C; Tabuchi K
Gan To Kagaku Ryoho; 1986 May; 13(5):1921-6. PubMed ID: 3707152
[TBL] [Abstract][Full Text] [Related]
18. DNA cross-linking and cytotoxicity induced by cis-diamminedichloroplatinum(II) in human normal and tumor cell lines.
Laurent G; Erickson LC; Sharkey NA; Kohn KW
Cancer Res; 1981 Sep; 41(9 Pt 1):3347-51. PubMed ID: 7196283
[TBL] [Abstract][Full Text] [Related]
19. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G
J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050
[TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
